Supreme Court ends pharmaceutical companies’ battle over TRIPS Agreement
On 3 April 2019 the Supreme Court rejected the extraordinary appeals filed by Pfizer against a Barcelona Court of Appeal judgment, confirming the dismissal of a patent infringement action against sildenafil generics competitors in Spain. Read More
